• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普罗布考在人血浆脂蛋白中分布的体外研究。

In vitro studies on the distribution of probucol among human plasma lipoproteins.

作者信息

Urien S, Riant P, Albengres E, Brioude R, Tillement J P

出版信息

Mol Pharmacol. 1984 Sep;26(2):322-7.

PMID:6482877
Abstract

The role of human plasma lipoproteins as carriers in the blood transport of the cholesterol-lowering and water-insoluble drug, probucol, was investigated in in vitro studies. [14C]Probucol was incubated in whole human blood, a serum pool, individual diluted sera, and isolated protein and lipoprotein fractions. In whole blood, about 90% partitioned in plasma. Following ultracentrifugal fractionation of the serum, it was found that less than 5% distributed in the d greater than 1.20 protein fraction (albumin-rich fraction) and more than 95% in the lipoprotein fractions. The distribution of probucol in the lipoprotein fractions correlated with the lipoprotein total lipid volume under saturation conditions (incubation of isolated lipoprotein fractions) as well as nonsaturation conditions (fractionation of serum exposed to [14C]probucol). Incubation of the albumin-rich fraction and of apolipoproteins originating from the isolated lipoprotein fractions showed that they account for a negligible part in the interaction of probucol with blood components. The probucol uptake of individual sera was shown to be correlated to the lipid content of the serum. When probucol was incubated in erythrocyte suspensions containing variable amounts of lipoproteins, probucol partitioned less in erythrocytes as the lipoprotein concentration increased in the suspension.

摘要

在体外研究中,对人血浆脂蛋白在降胆固醇且水不溶性药物普罗布考的血液运输中作为载体的作用进行了研究。将[14C]普罗布考与人全血、血清池、个体稀释血清以及分离的蛋白质和脂蛋白组分一起孵育。在全血中,约90%分布于血浆中。血清经超速离心分级分离后发现,小于5%分布于密度大于1.20的蛋白质组分(富含白蛋白的组分)中,而超过95%分布于脂蛋白组分中。在饱和条件下(分离的脂蛋白组分孵育)以及非饱和条件下(暴露于[14C]普罗布考的血清分级分离),普罗布考在脂蛋白组分中的分布与脂蛋白总脂体积相关。富含白蛋白的组分以及源自分离的脂蛋白组分的载脂蛋白的孵育表明,它们在普罗布考与血液成分的相互作用中所占比例可忽略不计。个体血清对普罗布考的摄取显示与血清的脂质含量相关。当普罗布考在含有不同量脂蛋白的红细胞悬液中孵育时,随着悬液中脂蛋白浓度的增加,普罗布考在红细胞中的分布减少。

相似文献

1
In vitro studies on the distribution of probucol among human plasma lipoproteins.普罗布考在人血浆脂蛋白中分布的体外研究。
Mol Pharmacol. 1984 Sep;26(2):322-7.
2
Effects of probucol on lipoprotein protein kinetics.普罗布考对脂蛋白动力学的影响。
Artery. 1982;10(2):95-8.
3
Preferential binding of chlordecone to the protein and high density lipoprotein fractions of plasma from humans and other species.
J Toxicol Environ Health. 1982 Jan;9(1):107-18. doi: 10.1080/15287398209530146.
4
The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.丙丁酚的降血脂作用。IIa型高脂蛋白血症中的药物转运和脂蛋白组成。
Atherosclerosis. 1985 Dec;58(1-3):261-8. doi: 10.1016/0021-9150(85)90071-1.
5
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.载脂蛋白C-III的脂蛋白分布及其与富含甘油三酯的残余脂蛋白在血浆中存在的关系。
Metabolism. 2001 Jan;50(1):112-9. doi: 10.1053/meta.2001.19452.
6
Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.普罗布考治疗对家族性高胆固醇血症患者血液及脂蛋白中脂蛋白胆固醇和药物水平的影响。
Atherosclerosis. 1986 Jan;59(1):47-56. doi: 10.1016/0021-9150(86)90032-8.
7
The use of zonal ultracentrifugation in the investigation of the binding of delta9-tetrahydrocannabinol by plasma lipoproteins.
Drug Metab Dispos. 1975 Jul-Aug;3(4):314-9.
8
Correlative design of electrophoretic and ultracentrifugal investigation of metabolic effects of probucol.普罗布考代谢效应的电泳和超速离心研究的相关设计
Artery. 1982;10(2):131-49.
9
Development of a lipoprotein profile using capillary electrophoresis and mass spectrometry.使用毛细管电泳和质谱法开发脂蛋白谱。
Electrophoresis. 1997 Sep;18(10):1796-806. doi: 10.1002/elps.1150181014.
10
Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitro.
Atherosclerosis. 1984 Sep;52(3):309-16. doi: 10.1016/0021-9150(84)90061-3.

引用本文的文献

1
Probucol mitigates high-fat diet-induced cognitive and social impairments by regulating brain redox and insulin resistance.普罗布考通过调节大脑氧化还原和胰岛素抵抗来减轻高脂饮食诱导的认知和社交障碍。
Front Neurosci. 2024 Apr 23;18:1368552. doi: 10.3389/fnins.2024.1368552. eCollection 2024.
2
Probucol is anti-hyperalgesic in a mouse peripheral nerve injury model of neuropathic pain.在小鼠神经性疼痛的外周神经损伤模型中,普罗布考具有抗痛觉过敏作用。
Neurobiol Pain. 2023 Aug 2;14:100141. doi: 10.1016/j.ynpai.2023.100141. eCollection 2023 Aug-Dec.
3
Tactics for preclinical validation of receptor-binding radiotracers.
受体结合放射性示踪剂临床前验证策略。
Nucl Med Biol. 2017 Jan;44:4-30. doi: 10.1016/j.nucmedbio.2016.08.015. Epub 2016 Sep 3.
4
Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol.
Eur J Drug Metab Pharmacokinet. 1997 Jul-Sep;22(3):201-6. doi: 10.1007/BF03189807.
5
Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs.新型苯并恶嗪利福霉素KRM-1648在大鼠和犬体内的药代动力学
Antimicrob Agents Chemother. 1996 Dec;40(12):2749-55. doi: 10.1128/AAC.40.12.2749.
6
Positive correlation between probucol in low density lipoprotein and LDL-lowering.普罗布考在低密度脂蛋白中的含量与降低低密度脂蛋白之间呈正相关。
Eur J Clin Pharmacol. 1993;45(4):343-6. doi: 10.1007/BF00265952.
7
Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.被动型海曼肾炎中的蛋白尿与脂质过氧化及IV型胶原上的加合物形成有关。
J Clin Invest. 1994 Oct;94(4):1577-84. doi: 10.1172/JCI117499.
8
Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.普罗布考。对其药理特性及在高胆固醇血症治疗应用的重新评估。
Drugs. 1989 Jun;37(6):761-800. doi: 10.2165/00003495-198937060-00002.
9
Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.普罗布考预防低密度脂蛋白氧化修饰作用的细胞内新作用位点的证据。一种新型水溶性普罗布考衍生物的应用。
J Clin Invest. 1992 May;89(5):1618-21. doi: 10.1172/JCI115757.